LivingGLP1
Study S000542

Effectiveness of Combined GLP-1/GIP Dual Agonist Therapy and Structured Exercise on Skeletal Muscle Morphology, Quality, and Physical Function in Overweight and Obese Individuals: a Randomized Controlled Trial Protocol

Registration

Registration
NCT07609160
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
SINGLE
Status
NOT_YET_RECRUITING
Enrollment
108
Start
2026-11-01
Primary completion
2027-11-30
Lead sponsor
Acibadem University
Conditions
Obesity; Sarcopenia; Overweight (Without Type 2 Diabetes) With Weight-related Comorbidities
Interventions
OTHER:Resistance exercise; OTHER:Lifestyle recommendations
Results posted
FALSE
Individual participant data sharing
NO
Secondary identifiers
OTHER:Grant proposal submitted

Registered primary outcomes

  • Change in muscle thickness [Baseline, 12 weeks, 24 weeks]
  • Muscle echo intensity [Baseline, 12 weeks, 24 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.